We are confident that our cell model to study the effect of drugs on the modulation of tau aggregation and tau-microtubule interaction and the identification of the small molecule PHOX15 as a promising polypharmacological drug candidate will help advance approaches that specifically target the key traits of tauopathies. This evidence concerns the gene MAPT and tauopathy.